AAAAAA

   
Results: 1-3 |
Results: 3
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001)
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001), CANCER RES, 61(20), 2001, pp. 7703-7703
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor, CANCER RES, 61(14), 2001, pp. 5349-5354
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR
Authors: Luwor, RB Johns, TG Murone, C Huang, HJS Cavenee, WK Ritter, G Old, LJ Burgess, AW Scott, AM
Citation: Rb. Luwor et al., Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR, CANCER RES, 61(14), 2001, pp. 5355-5361
Risultati: 1-3 |